Amy Brown

Amy has spent the last 19 years writing about the pharmaceutical and biotechnology sectors, mostly for Evaluate Vantage. As a founding member of the website, she helped shape and direct its content in roles including news editor and deputy editor.

Prior to Vantage Amy covered pharmaceuticals for Thomson Financial News and the newswire AFX News. She has also hosted panels at industry events and contributed articles about the biopharma sector to Nature Drug Discovery, the Sunday Times, and Corporate Financier.

Amy started her career as a financial journalist at Bloomberg News.